Literature DB >> 23430479

Influence of bariatric surgery on the use and pharmacokinetics of some major drug classes.

Jan Peter Yska1, Susanne van der Linde, Véronique V Tapper, Jan A Apers, Marloes Emous, Erik R Totté, Bob Wilffert, Eric N van Roon.   

Abstract

The purpose of this review is to evaluate the influence of bariatric surgery on the use and pharmacokinetics of some frequently used drugs. A PubMed literature search was conducted. Literature was included on influence of bariatric surgery on pharmacoepidemiology and pharmacokinetics. Drug classes to be searched for were antidepressants, antidiabetics, statins, antihypertensive agents, corticosteroids, oral contraceptives, and thyroid drugs. A reduction in the use of medication by patients after bariatric surgery has been reported for various drug classes. Very few studies have been published on the influence of bariatric surgery on the pharmacokinetics of drugs. After bariatric surgery, theoretically, reduced drug absorption may occur. Correct dosing and choosing the right dosage form for drugs used by patients after bariatric surgery are necessary for optimal pharmacotherapy. Therefore, more clinical studies are needed on the influence of bariatric surgery on the pharmacokinetics of major drugs.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23430479     DOI： 10.1007/s11695-013-0882-6

Source DB:  PubMed          Journal:  Obes Surg        ISSN： 0960-8923            Impact factor:   4.129


  58 in total

Review 1.  A systematic review of drug absorption following bariatric surgery and its theoretical implications.

Authors:  R Padwal; D Brocks; A M Sharma
Journal:  Obes Rev       Date:  2009-06-02       Impact factor: 9.213

Review 2.  Impact of bariatric surgery on female reproduction.

Authors:  Zaher O Merhi
Journal:  Fertil Steril       Date:  2009-08-08       Impact factor: 7.329

Review 3.  Contraceptive use among women with a history of bariatric surgery: a systematic review.

Authors:  Melissa E Paulen; Lauren B Zapata; Catherine Cansino; Kathryn M Curtis; Denise J Jamieson
Journal:  Contraception       Date:  2010-03-29       Impact factor: 3.375

Review 4.  Bariatric surgery for type 2 diabetes.

Authors:  John B Dixon; Carel W le Roux; Francesco Rubino; Paul Zimmet
Journal:  Lancet       Date:  2012-06-09       Impact factor: 79.321

5.  Impact of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on HbA1c blood level and pharmacological treatment of type 2 diabetes mellitus in severe or morbidly obese patients. Results of a multicenter prospective study at 1 year.

Authors:  David Nocca; Fabre Guillaume; Patrick Noel; Marie Christine Picot; Rajesh Aggarwal; Moez El Kamel; Roxanne Schaub; Charles de Seguin de Hons; Eric Renard; Jean Michel Fabre
Journal:  Obes Surg       Date:  2011-06       Impact factor: 4.129

6.  Short-term medication cost savings for treating hypertension and diabetes after gastric bypass.

Authors:  Saber Ghiassi; John Morton; Nina Bellatorre; Dan Eisenberg
Journal:  Surg Obes Relat Dis       Date:  2011-05-27       Impact factor: 4.734

7.  Medication use patterns after gastric bypass surgery for weight management.

Authors:  Margaret Malone; Sharon A Alger-Mayer
Journal:  Ann Pharmacother       Date:  2005-03-01       Impact factor: 3.154

8.  Significantly altered systemic exposure to atorvastatin acid following gastric bypass surgery in morbidly obese patients.

Authors:  I B Skottheim; K Stormark; H Christensen; G S Jakobsen; J Hjelmesaeth; T Jenssen; J L E Reubsaet; R Sandbu; A Asberg
Journal:  Clin Pharmacol Ther       Date:  2009-06-03       Impact factor: 6.875

9.  Improvement of type 2 diabetes mellitus (T2DM) after bariatric surgery--who fails in the early postoperative course?

Authors:  C Jurowich; A Thalheimer; D Hartmann; G Bender; F Seyfried; C T Germer; C Wichelmann
Journal:  Obes Surg       Date:  2012-10       Impact factor: 4.129

Review 10.  Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes.

Authors:  Ele Ferrannini; Geltrude Mingrone
Journal:  Diabetes Care       Date:  2009-03       Impact factor: 19.112
View more
  23 in total

Review 1.  Oral Anticoagulant Use After Bariatric Surgery: A Literature Review and Clinical Guidance.

Authors:  Karlyn A Martin; Craig R Lee; Timothy M Farrell; Stephan Moll
Journal:  Am J Med       Date:  2017-02-01       Impact factor: 4.965

Review 2.  Altered drug disposition following bariatric surgery: a research challenge.

Authors:  H Karl Greenblatt; David J Greenblatt
Journal:  Clin Pharmacokinet       Date:  2015-06       Impact factor: 6.447

3.  Systematic review of drug bioavailability following gastrointestinal surgery.

Authors:  Manuela Moreno Santamaría; José Javier Arenas Villafranca; Jimena Abilés; Alberto Fernández López; Lucia Visiedo Rodas; Begoña Tortajada Goitia; Pilar Utrilla Navarro
Journal:  Eur J Clin Pharmacol       Date:  2018-08-22       Impact factor: 2.953

4.  Indications for Surgery for Obesity and Weight-Related Diseases: Position Statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO).

Authors:  Maurizio De Luca; Luigi Angrisani; Jacques Himpens; Luca Busetto; Nicola Scopinaro; Rudolf Weiner; Alberto Sartori; Christine Stier; Muffazal Lakdawala; Aparna G Bhasker; Henry Buchwald; John Dixon; Sonja Chiappetta; Hans-Christian Kolberg; Gema Frühbeck; David B Sarwer; Michel Suter; Emanuele Soricelli; Mattias Blüher; Ramon Vilallonga; Arya Sharma; Scott Shikora
Journal:  Obes Surg       Date:  2016-08       Impact factor: 4.129

5.  Proximal Roux-en-Y gastric bypass alters drug absorption pattern but not systemic exposure of CYP3A4 and P-glycoprotein substrates.

Authors:  Lingtak-Neander Chan; Yvonne S Lin; Jessica C Tay-Sontheimer; Dorothy Trawick; Brant K Oelschlager; David R Flum; Kristen K Patton; Danny D Shen; John R Horn
Journal:  Pharmacotherapy       Date:  2015-03-10       Impact factor: 4.705

Review 6.  Obesity and hormonal contraceptive efficacy.

Authors:  Jennifer A Robinson; Anne E Burke
Journal:  Womens Health (Lond)       Date:  2013-09

Review 7.  Is Bariatric Surgery Effective in Reducing Comorbidities and Drug Costs? A Systematic Review and Meta-Analysis.

Authors:  E C Lopes; I Heineck; G Athaydes; N G Meinhardt; K E P Souto; A T Stein
Journal:  Obes Surg       Date:  2015-09       Impact factor: 4.129

8.  Effect of Roux-en-Y gastric bypass on the bioavailability of metoprolol from immediate and controlled release tablets: a single oral dose study before and after surgery.

Authors:  Jan Peter Yska; Jacquelien T M Wanders; Blessing Odigie; Jan A Apers; Marloes Emous; Erik R E Totté; E Christiaan Boerma; Froukje L Ubels; Herman J Woerdenbag; Henderik W Frijlink; Bob Wilffert; Eric N van Roon
Journal:  Eur J Hosp Pharm       Date:  2019-02-15

9.  The Effect of Roux-en-Y Gastric Bypass Surgery in Morbidly Obese Patients on Pharmacokinetics of (Acetyl)Salicylic Acid and Omeprazole: the ERY-PAO Study.

Authors:  Lieke Mitrov-Winkelmolen; Marie-Christine W van Buul-Gast; Dingeman J Swank; Hans W P M Overdiek; Ron H N van Schaik; Daan J Touw
Journal:  Obes Surg       Date:  2016-09       Impact factor: 4.129

10.  Influence of bariatric surgery on the use of medication.

Authors:  Jan Peter Yska; Douwe H van der Meer; Albert R Dreijer; Willeke Eilander; Jan A Apers; Marloes Emous; Erik R E Totté; Bob Wilffert; Eric N van Roon
Journal:  Eur J Clin Pharmacol       Date:  2015-11-03       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.